TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9493701

Group type: EXPERIMENTAL
Intervention: Barnidipine 10 mg
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Barnidipine 20 mg
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Barnidipine 30 mg
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 8227108

Group type: EXPERIMENTAL
Intervention: Compression sclerotherapy (CST; n = 78)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Radical operation (OP; n = 74)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: CST combined with high tie under local anesthesia (HT + CST; n = 63)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Foot-volumetric parameters (all groups)
Number of subjects: 211
Study: 3947505

Group type: EXPERIMENTAL
Intervention: 75 mg diclofenac sodium
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 150 mg diclofenac sodium
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 60 mg codeine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 30392496

Group type: EXPERIMENTAL
Intervention: PsP 750mg/day in 3 divided doses for 90 days
Number of subjects: 71
Study: 27906080

Group type: EXPERIMENTAL
Intervention: Tonic stimulation for 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Burst stimulation for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tonic stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Burst stimulation
Number of subjects: 0
Study: 25335686

Group type: EXPERIMENTAL
Intervention: Milk enriched with sterols (2.24 g per day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (skim milk)
Number of subjects: 19
Study: 22417253

Group type: EXPERIMENTAL
Intervention: Oral laquinimod 0.6 mg once daily
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1106
Study: 20709206

Group type: EXPERIMENTAL
Intervention: Screened group (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secondary endpoints
Number of subjects: 0
Study: 19084097

Group type: EXPERIMENTAL
Intervention: Metformin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 0
Study: 15657221

Group type: EXPERIMENTAL
Intervention: Treadmill exercise (Bruce protocol)
Number of subjects: 26
Study: 12604533

Group type: EXPERIMENTAL
Intervention: Amoxicillin 25 mg/kg/dose b.i.d.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Amoxicillin 15 mg/kg/dose t.i.d.
Number of subjects: 66
Study: 10390311

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) of wrist extensors (3 times 30 minutes daily for 8 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electrical stimulation (ES) of wrist extensors
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard rehabilitation treatment
Number of subjects: 60
Study: 8894861

Group type: EXPERIMENTAL
Intervention: Alkalinised lignocaine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Non-alkalinised lignocaine
Number of subjects: 98
Study: 2005315

Group type: EXPERIMENTAL
Intervention: Exposure to isocyanates
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Exposure to IgE sensitizing agents
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Exposure to western red cedar
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Typical patterns of reactions
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Atypical reactions
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Visual assessment vs polynomial fit analysis
Number of subjects: 69
Study: 6650801

Group type: EXPERIMENTAL
Intervention: Midazolam 0.2 mg kg‐1 i.v.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopentone 5 mg kg‐1 i.v.
Number of subjects: 40
Study: 30941435

Group type: EXPERIMENTAL
Intervention: Dietary ME levels of 2,600; 2,700; 2,800; 2,900; and 3,000 kcal/kg of feed
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Beak trimming once (7 days old)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Beak trimming twice (7 and 70 days old)
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Dietary ME levels
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Beak trimming once
Number of subjects: 640

Group type: EXPERIMENTAL
Intervention: Increasing dietary ME levels and beak trimming hens once
Number of subjects: 640
Study: 30001765

Group type: EXPERIMENTAL
Intervention: UAV technology
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Practice (SP)
Number of subjects: 40
Study: 26668200

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning
Number of subjects: 258

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 258
Study: 25129531

Group type: EXPERIMENTAL
Intervention: Living with Bipolar (LWB) intervention
Number of subjects: 122

Group type: COMPARATOR
Intervention: Waiting List Control (WLC)
Number of subjects: 122
Study: 22055112

Group type: EXPERIMENTAL
Intervention: FOLF-CB (cetuximab 400 mg/m2 day 1 cycle 1; subsequent doses 250 mg/m2 weekly, along with bevacizumab, leucovorin, and 5-FU)
Number of subjects: 247

Group type: COMPARATOR
Intervention: mFOLFOX6-B (bevacizumab 5 mg/kg, oxaliplatin 85 mg/m2, leucovorin 400 mg/m2, and 5-FU 400 mg/m2 then 1200 mg/m2/day for 48 hours)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: FOLF-CB
Number of subjects: 247

Group type: COMPARATOR
Intervention: mFOLFOX6-B
Number of subjects: 247
Study: 19182972

Group type: COMPARATOR
Intervention: 2% NaF
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CO(2) laser (1 W, continuous wave mode, for 10 sec)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (30 Hz, 60 mJ for 10 sec, without water/air spray)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CO(2) + 2% NaF
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Er:YAG + 2% NaF
Number of subjects: 50
Study: 17452287

Group type: EXPERIMENTAL
Intervention: Memantine (30mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 16055645

Group type: EXPERIMENTAL
Intervention: Training in Oriental medicine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Length of training in Oriental medicine
Number of subjects: 0
Study: 12418051

Group type: EXPERIMENTAL
Intervention: FOBT and endoscopy with polypectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic tests and imaging studies
Number of subjects: 0
Study: 9431330

Group type: EXPERIMENTAL
Intervention: Case-managed residential care (CMRC)
Number of subjects: 358

Group type: COMPARATOR
Intervention: 21-day hospital program with referral to community services
Number of subjects: 358
Study: 7730879

Group type: EXPERIMENTAL
Intervention: HIV Symptom Index (12 symptoms: fatigue, fevers, headache, imbalance, paresthesias, memory loss, cough, nausea, diarrhea, sadness, sleep disturbance, skin problems)
Number of subjects: 148
Study: 2660550

Group type: EXPERIMENTAL
Intervention: Sucralfate suspension 1 g/10 ml four times per day
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292

Group type: COMPARATOR
Intervention: Cigarette smoking (regardless of treatment group)
Number of subjects: 292
Study: 30813112

Group type: EXPERIMENTAL
Intervention: Nurse-led telephonic case management
Number of subjects: 1350

Group type: COMPARATOR
Intervention: Specialty outpatient palliative care
Number of subjects: 1350
Study: 28389582

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) Satisfaction Survey
Number of subjects: 158
Study: 26417132

Group type: EXPERIMENTAL
Intervention: Oropharyngeal packing (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nasopharyngeal packing (Group B)
Number of subjects: 40
Study: 23143698

Group type: EXPERIMENTAL
Intervention: Basketball shoes (BS)
Number of subjects: 12
Study: 20724681

Group type: EXPERIMENTAL
Intervention: Active water treatment units
Number of subjects: 769

Group type: COMPARATOR
Intervention: Sham water treatment units
Number of subjects: 769
Study: 19485582

Group type: EXPERIMENTAL
Intervention: Coping Power‐training plus feedback (CP‐TF)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Coping Power‐basic training (CP‐BT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comparison condition
Number of subjects: 57
Study: 16485765

Group type: EXPERIMENTAL
Intervention: Spatiotemporal QRST cancellation (STC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Principal component analysis (PCA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Independent component analysis (ICA)
Number of subjects: 30
Study: 15561950

Group type: EXPERIMENTAL
Intervention: GAD antibody positive patients
Number of subjects: 4134

Group type: COMPARATOR
Intervention: GAD antibody negative patients
Number of subjects: 4134
Study: 11772575

Group type: COMPARATOR
Intervention: high-O(2) soft lens (6-night EW)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: hyper-O(2) soft lens (30-night EW)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: hyper-O(2) rigid gas-permeable lens (30-night EW)
Number of subjects: 178
Study: 9530380

Group type: EXPERIMENTAL
Intervention: Coronary artery calcium score
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Coronary stenosis
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Carotid IMT
Number of subjects: 50
Study: 7912478

Group type: EXPERIMENTAL
Intervention: Mivacurium
Number of subjects: 6

Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Doxacurium
Number of subjects: 6
Study: 2917399

Group type: EXPERIMENTAL
Intervention: Opti-Free chemical disinfectant under exaggerated conditions (Group A)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Opti-Free chemical disinfectant under normal daily use (Group A)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal daily use regimen (Group B)
Number of subjects: 51
Study: 30273819

Group type: EXPERIMENTAL
Intervention: Leucine-enriched amino acid supplement
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no leucine-enriched amino acid supplement)
Number of subjects: 44
Study: 28545580

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) after 5 therapy-preparing sessions
Number of subjects: 48
Study: 26325427

Group type: EXPERIMENTAL
Intervention: Non-ceramic hydroxyapatite (ncHA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intra-oral autologous bone graft
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both groups (ncHA and autologous bone)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Implant stability quotient (ISQ)
Number of subjects: 11
Study: 23871112

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted phacoemulsification
Number of subjects: 2

Group type: COMPARATOR
Intervention: Standard phacoemulsification (control group)
Number of subjects: 2
Study: 22616337

Group type: EXPERIMENTAL
Intervention: SMS intervention (messages sent once every 3 days for 1 year)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 215
Study: 19624628

Group type: EXPERIMENTAL
Intervention: Supraclavicular block with 2% lidocaine 25‐30 ml and adrenaline 5 microg.ml(‐1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Infraclavicular block with 2% lidocaine 25‐30 ml and adrenaline 5 microg.ml(‐1)
Number of subjects: 60
Study: 17081212

Group type: EXPERIMENTAL
Intervention: Dual-chamber pacemaker implantation
Number of subjects: 262

Group type: COMPARATOR
Intervention: Cumulative right ventricular pacing ≥ 50%
Number of subjects: 262
Study: 15112033

Group type: EXPERIMENTAL
Intervention: Critical Care Outreach service
Number of subjects: 7450

Group type: COMPARATOR
Intervention: Control
Number of subjects: 7450
Study: 11706909

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Acetaminophen (600 mg) with codeine (60 mg) and caffeine (15 mg) (Tylenol No. 3)
Number of subjects: 237
Study: 17008969

Group type: EXPERIMENTAL
Intervention: Endoscopic decompression (group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Open decompression (group A)
Number of subjects: 120
Study: 7964196

Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mobilization
Number of subjects: 30
Study: 31463689

Group type: EXPERIMENTAL
Intervention: Two 4.5‐mm cannulated partially threaded screws
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Suture‐button construct
Number of subjects: 9
Study: 29095000

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (40% carbohydrates, 20% protein, 40% fats)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard diet (50% carbohydrates, 20% protein, 30% fats)
Number of subjects: 88
Study: 26450920

Group type: EXPERIMENTAL
Intervention: Axitinib for 28 days followed by radical prostatectomy and pelvic lymph node dissection (RP/PLND)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Radical prostatectomy and pelvic lymph node dissection (RP/PLND) alone
Number of subjects: 46
Study: 23312676

Group type: EXPERIMENTAL
Intervention: PS-Omega3 (300mg PS-Omega3/day)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: PS-Omega3 (150mg PS-Omega3/day) during open-label phase
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 21854596

Group type: EXPERIMENTAL
Intervention: Outreach intervention (trained community outreach workers)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 16
Study: 18334689

Group type: EXPERIMENTAL
Intervention: Monthly personal contact
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Interactive technology‐based intervention
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Self‐directed control
Number of subjects: 1032
Study: 17142406

Group type: EXPERIMENTAL
Intervention: Hip core decompression followed by physical therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Physical therapy alone
Number of subjects: 38
Study: 14563339

Group type: EXPERIMENTAL
Intervention: Combination therapy with abciximab (0.25mg/kg bolus and 0.125 microg/kg/min for 12h) and half‐dose reteplase (two boluses of 5U 30 min apart) with reduced‐dose heparin (60 Ukg(‐1) bolus, maximum 5000 U, followed by an infusion of 7 Ukg(‐1)h(‐1))
Number of subjects: 16588

Group type: COMPARATOR
Intervention: Reteplase alone (10 U bolus twice, 30 min apart) with standard‐dose heparin (5000 U bolus followed by an infusion of 1000 Uh(‐1) for patients > or =80 kg and 800 Uh(‐1) for those <80 kg)
Number of subjects: 16588

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 16588

Group type: COMPARATOR
Intervention: Reteplase alone
Number of subjects: 16588
Study: 11056590

Group type: EXPERIMENTAL
Intervention: HIV‐1 Immunogen administered intramuscularly every 12 weeks
Number of subjects: 2527

Group type: COMPARATOR
Intervention: Placebo (incomplete Freund adjuvant)
Number of subjects: 2527
Study: 8752247

Group type: EXPERIMENTAL
Intervention: Postoperative nasogastric tube decompression
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intra-operative orogastric tube decompression
Number of subjects: 110
Study: 1433580

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 532

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 532
Study: 4029017

Group type: EXPERIMENTAL
Intervention: Temocillin 0.5 g intravenous
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Temocillin 1 g intravenous
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Temocillin 2 g intravenous
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Temocillin 0.5 g intramuscular
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dose-reduction factors for temocillin
Number of subjects: 36
Study: 31356125

Group type: EXPERIMENTAL
Intervention: Riding with an impaired driver (RWID)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Driving under the influence (DUI)
Number of subjects: 668
Study: 29415606

Group type: EXPERIMENTAL
Intervention: Ibuprofen medicated plaster
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo plaster
Number of subjects: 210
Study: 26611500

Group type: EXPERIMENTAL
Intervention: 10% SSS in ET medium (Group A)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: 20% SSS in ET medium (Group B)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: 50% SSS in ET medium (Group C)
Number of subjects: 750
Study: 24849439

Group type: EXPERIMENTAL
Intervention: Group A (Narcotrend index maintained at D0 level)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Group B (Narcotrend index maintained at D2 level)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Group C (Narcotrend index maintained at E1 level)
Number of subjects: 105
Study: 22929601

Group type: EXPERIMENTAL
Intervention: 50% sucrose
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 75% sucrose
Number of subjects: 113

Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 113
Study: 20558197

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 2203
Study: 17378911

Group type: EXPERIMENTAL
Intervention: Ghrelin concentration greater than 3,200 pg/mL (fourth quartile)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Overweight subjects (BMI >= 25)
Number of subjects: 52
Study: 15741228

Group type: EXPERIMENTAL
Intervention: Non-fluoroscopic navigation system
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (without non-fluoroscopic navigation)
Number of subjects: 72
Study: 11931786

Group type: COMPARATOR
Intervention: 1 Gy (4 x 0.25 Gy)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: 8 Gy (4 x 2 Gy)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: 16 Gy (4 x 4 Gy)
Number of subjects: 161
Study: 9788404

Group type: EXPERIMENTAL
Intervention: Combined chemoradiotherapy (5-fluorouracil, mitomycin C, and radiation therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 0
Study: 8607315

Group type: EXPERIMENTAL
Intervention: Ephedrine 0.1 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 12
Study: 2650015

Group type: EXPERIMENTAL
Intervention: Acyclovir in propylenglycol (40% cream)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 96
Study: 769975

Group type: EXPERIMENTAL
Intervention: DTIC, BCNU, and vincristine
Number of subjects: 0

Group type: COMPARATOR
Intervention: DTIC, BCNU, and actinomycin D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adriamycin and DTIC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclophosphamide, vincristine, and methotrexate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABVD (adriamycin, bleomycin, vinblastine, and DTIC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MOPP (mechlorethamine, vincristine, prednisone, and procarbazine)
Number of subjects: 0
Study: 31617562

Group type: EXPERIMENTAL
Intervention: Clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician (FP)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 174
Study: 31185323

Group type: EXPERIMENTAL
Intervention: PDT + nystatin
Number of subjects: 66

Group type: COMPARATOR
Intervention: Nystatin
Number of subjects: 66
Study: 28118537

Group type: EXPERIMENTAL
Intervention: AMG 811 (180 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 25811379

Group type: EXPERIMENTAL
Intervention: Indoor Residual Spraying (IRS) in addition to Insecticide Treated Nets (ITNs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Insecticide Treated Nets (ITNs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Living in a sprayed village
Number of subjects: 50
Study: 23652892

Group type: EXPERIMENTAL
Intervention: Tazarotene foam, 0.1%
Number of subjects: 1486

Group type: COMPARATOR
Intervention: Vehicle foam
Number of subjects: 1486
Study: 21814547

Group type: EXPERIMENTAL
Intervention: TCF7L2 rs7903146 T allele
Number of subjects: 2994
Study: 19264723

Group type: EXPERIMENTAL
Intervention: Sterile water
Number of subjects: 186

Group type: COMPARATOR
Intervention: 10% povidone-iodine
Number of subjects: 186
Study: 17455207

Group type: EXPERIMENTAL
Intervention: Weekend 5-ASA enema (1 g twice a week) plus oral 5-ASA (3 g/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral 5-ASA only (3 g/day)
Number of subjects: 24
Study: 14522627

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 4% gel (BID)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Adapalene 0.1% gel (QD)
Number of subjects: 178
Study: 10968648

Group type: EXPERIMENTAL
Intervention: Acupuncture in combination with tooth extraction
Number of subjects: 22

Group type: COMPARATOR
Intervention: Routine tooth extraction alone (control group)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Acupuncture used in combination with local anesthesia
Number of subjects: 22
Study: 9202556

Group type: EXPERIMENTAL
Intervention: SR alfuzosin 5 mg twice daily
Number of subjects: 588

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 588
Study: 1283576

Group type: EXPERIMENTAL
Intervention: Verapamil SR 240 mg/day
Number of subjects: 1464

Group type: COMPARATOR
Intervention: Chlorthalidone 25 mg/day
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1464
Study: 3823637

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg sublingually)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31072706

Group type: EXPERIMENTAL
Intervention: MV ≥24 hours
Number of subjects: 1994

Group type: EXPERIMENTAL
Intervention: MV ≥36 hours
Number of subjects: 1994

Group type: EXPERIMENTAL
Intervention: MV ≥48 hours
Number of subjects: 1994

Group type: EXPERIMENTAL
Intervention: Model performance for predicting prolonged MV
Number of subjects: 1994
Study: 28415881

Group type: EXPERIMENTAL
Intervention: Step by Step treatment protocol (intervention)
Number of subjects: 57
Study: 27367159

Group type: EXPERIMENTAL
Intervention: Spironolactone 20 mg once daily (up to 40 mg once daily for 4 weeks if required)
Number of subjects: 30
Study: 25069531

Group type: EXPERIMENTAL
Intervention: 10‐mg metoclopramide thrice daily for 15 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: 10‐mg placebo thrice daily for 15 days
Number of subjects: 36
Study: 22614994

Group type: EXPERIMENTAL
Intervention: Diet-exercise intervention delivered via mailed print materials and telephone counseling
Number of subjects: 641

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 641